{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T16:50:06Z","timestamp":1754153406698,"version":"3.41.2"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1097\/igc.0b013e31821dc8e5","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T04:29:16Z","timestamp":1311654556000},"page":"988-995","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Preparation of Human Papillomavirus Type 58 Vaccine and Exploring Its Biological Activity and Immunogenicity In Vitro"],"prefix":"10.1016","volume":"21","author":[{"given":"Dongrui","family":"Deng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shujie","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyang","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Sima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0005","first-page":"74","article-title":"Global cancer statistics, 2002","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0010","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1093\/oxfordjournals.epirev.a036020","article-title":"Epidemiology of genital human papillomavirus infection","volume":"10","author":"Koutsky","year":"1988","journal-title":"Epidemiol Rev."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0015","doi-asserted-by":"crossref","unstructured":"zur Hausen H. Papillomavirus infectionsVa major cause of human cancers. Biochim Biophys Acta. 1996;1288:F55-F78.","DOI":"10.1016\/0304-419X(96)00020-0"},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0020","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0030","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0035","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000052925","article-title":"Clinical and prognostic significance of human papillomavirus in a Chinese population of cervical cancers","volume":"51","author":"Lo","year":"2001","journal-title":"Gynecol Obstet Invest."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1386-6532(00)00125-6","article-title":"Human papillomavirus and cancer: the epidemiological evidence","volume":"19","author":"Munoz","year":"2000","journal-title":"J Clin Virol."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0042-6822(90)90560-E","article-title":"Molecular cloning of a novel human papillomavirus (type 58) from an invasive cervical carcinoma","volume":"177","author":"Matsukura","year":"1990","journal-title":"Virology."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0050","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/(SICI)1097-0215(19970207)70:4<408::AID-IJC6>3.0.CO;2-#","article-title":"Human papillomavirus types 52 and 58 are prevalent in cervical cancers from Chinese women","volume":"70","author":"Huang","year":"1997","journal-title":"Int J Cancer."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0055","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/(SICI)1096-9071(199910)59:2<232::AID-JMV18>3.0.CO;2-7","article-title":"High prevalence of human papillomavirus type 58 in Chinese women with cervical cancer and precancerous lesions","volume":"59","author":"Chan","year":"1999","journal-title":"J Med Virol."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0060","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/(SICI)1097-0215(20000215)85:4<486::AID-IJC7>3.0.CO;2-S","article-title":"Human papillomavirus infection and invasive cervical cancer in Paraguay","volume":"85","author":"Rolon","year":"2000","journal-title":"Int J Cancer."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0065","first-page":"1129","article-title":"Human papillomavirus infection at the United States-Mexico border: implications for cervical cancer prevention and control","volume":"10","author":"Giuliano","year":"2001","journal-title":"Cancer Epidemiol Biomarkers Prev."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0070","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1006\/viro.1996.0466","article-title":"Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies","volume":"223","author":"Christensen","year":"1996","journal-title":"Virology."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0075","doi-asserted-by":"crossref","first-page":"3959","DOI":"10.1128\/jvi.69.6.3959-3963.1995","article-title":"Immunization with viruslike particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection","volume":"69","author":"Breitburd","year":"1995","journal-title":"J Virol."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0080","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/jvi.67.1.315-322.1993","article-title":"Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins","volume":"67","author":"Hagensee","year":"1993","journal-title":"J Virol."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0085","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S1097-2765(00)80449-9","article-title":"Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16","volume":"5","author":"Chen","year":"2000","journal-title":"Mol Cell."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0090","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02255810","article-title":"Preventive and therapeutic vaccines for human papillomavirus-associated cervical cancers","volume":"7","author":"Ling","year":"2000","journal-title":"J Biomed Sci."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0095","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/0042-6822(91)90791-9","article-title":"Human papillomavirus type 58 DNA sequence","volume":"185","author":"Kirii","year":"1991","journal-title":"Virology."},{"journal-title":"Instruction Manual of Bac-to-Bac Baculovirus Expression Systems","year":"2004","key":"10.1097\/IGC.0b013e31821dc8e5_bb0100"},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0105","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0188-0128(99)00026-3","article-title":"Chimeric virus-like particles of the human papillomavirus type 16 (HPV 16) as a prophylactic and therapeutic vaccine","volume":"30","author":"Jochmus","year":"1999","journal-title":"Arch Med Res."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0110","first-page":"211","article-title":"Production and verif ication of human papillomavirus type 18 vaccine in vitro","volume":"20","author":"Liao","year":"2008","journal-title":"Oncol Rep."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0115","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1073\/pnas.95.4.1800","article-title":"Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model","volume":"95","author":"Greenstone","year":"1998","journal-title":"Proc Natl Acad Sci U SA."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0120","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1006\/viro.2000.0435","article-title":"Papillomavirus virus-like particles for the delivery of multiple cytotoxic T cell epitopes","volume":"273","author":"Liu","year":"2000","journal-title":"Virology."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0125","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1099\/0022-1317-82-11-2799","article-title":"Chimeric papillomavirus-like particles expressing a foreign epitope on capsid surface loops","volume":"82","author":"Slupetzky","year":"2001","journal-title":"J Gen Virol."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1515\/BC.1999.045","article-title":"Induction of HPV16 capsid protein-specific human T cell responses by virus-like particles","volume":"380","author":"Rudolf","year":"1999","journal-title":"Biol Chem."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0135","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1006\/viro.1996.0473","article-title":"Carboxyl terminus of bovine papillomavirus type-1 L1 protein is not required for capsid formation","volume":"223","author":"Jeanette","year":"1996","journal-title":"Virology."},{"issue":"pt 7","key":"10.1097\/IGC.0b013e31821dc8e5_bb0140","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1099\/0022-1317-75-7-1647","article-title":"Human papillomavirus (HPV) type 18 E7 protein is a short-lived steroid-inducible phosphoprotein in HPV-transformed cell lines","volume":"75","author":"Selvey","year":"1994","journal-title":"J Gen Virol."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0145","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0264-410X(00)00370-4","article-title":"Immunological analyses of human papillomavirus capsids","volume":"19","author":"Giroglou","year":"2001","journal-title":"Vaccine."},{"key":"10.1097\/IGC.0b013e31821dc8e5_bb0150","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1128\/JVI.76.13.6480-6486.2002","article-title":"Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses","volume":"76","author":"Combita","year":"2002","journal-title":"J Virol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045857?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045857?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.lww.com\/ijgc\/Fulltext\/10.1097\/IGC.0b013e31821dc8e5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T01:13:07Z","timestamp":1753233187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24045857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["S1048891X24045857"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e31821dc8e5","relation":{},"ISSN":["1048-891X"],"issn-type":[{"type":"print","value":"1048-891X"}],"subject":[],"published":{"date-parts":[[2011,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Preparation of Human Papillomavirus Type 58 Vaccine and Exploring Its Biological Activity and Immunogenicity In Vitro","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e31821dc8e5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2011 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}